Skip to main content
OpenTrials
Completed

NCT Number: NCT05049824

Procedure for Duodenal-Ileal Diversion for Patients With Weight Regain Following Sleeve Gastrectomy

Study will monitor weight loss and metabolic indicators for subjects in single-center, single arm trial.

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Centro Medico Teknon

Barcelona, Spain

About this study

Single-Center, Open-label Pilot Study to Evaluate the Safety and Effectiveness of the GI Windows Single Neodymium Magnet Anastomosis Procedure When Used to Create a Duodenal-Ileal Diversion for Subjects with Inadequate Weight Loss or Weight Regain Following Sleeve Gastrectomy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 22-65 years at screening
  • Body mass index (BMI) ≥35 and ≤50
  • Patient is ≥12 months but ≤ 60 months post sleeve gastrectomy who have inadequate weight loss or weight regain.
  • Weight stable over 3-month period
  • Negative H. pylori breath test
  • Agrees to refrain from any type of additional bariatric or reconstructive surgery that would affect body weight for a duration of 2 years
  • If female, subject must commit to not becoming pregnant for 24 months and agree to use contraception during this period
  • Able to understand and sign informed consent documents.

Exclusion criteria

  • Known or suspected allergy to nickel or titanium or nitinol
  • Contraindication to general anesthesia
  • Previous technical difficulty or failed endoscopy or contraindication to endoscopy of upper GI series
  • Any previous major surgery on the stomach (excluding sleeve gastrectomy), duodenum, hepatobiliary tree (excluding gallbladder), pancreas, or right colon.
  • Clinically significant findings during screening endoscopy at target region for compression anastomosis
  • Uncontrolled hypertension
  • Pre-existing severe comorbid cardio-respiratory disease
  • History of type 1 diabetes or poorly controlled type 2 diabetes
  • Abnormal liver biochemistry
  • History of chronic gastrointestinal disease
  • Specific genetic or hormonal cause of obesity
  • Recent tobacco/nicotine product cessation (within 3 months prior)

Treatment and study plan

Self Forming Magnetic (SFM) Anastomosis System

Device

The SFM will be placed using an endoscope in the duodenum and laparoscopically into the ileum. A compression anastomosis will be created in each of the subjects and the diversion of enteral flow from the duodenum to ileum will create a metabolic effect that will induce weight loss and impact metabolic disease indicators

Primary outcomes

  1. Weight Loss

    Time frame: 12 Months

    • Weight loss measured as a percent of total body weight (TBW)

Secondary outcomes

  1. Percent responders

    Time frame: 12 Months

    Percent of subjects losing at least 10% and 20% of baseline weight from baseline

  2. Excess weight loss

    Time frame: 12 Months

    Mean change in Excess weight loss from baseline

  3. Change in serum lipids

    Time frame: 12 Months

    Mean change in serum lipids from baseline

  4. Change in blood pressure

    Time frame: 12 Months

    Mean change in blood pressure from baseline

  5. Change in fasting glucose

    Time frame: 12 Months

    Mean change in fasting glucose in subjects with T2DM at baseline

  6. Change in HbA1c

    Time frame: 12 Months

    Mean change in HbA1c in subjects with T2DM at baseline

  7. Change in BMI

    Time frame: 12 Months

    Mean change in BMI from baseline

  8. Change in Absolute Weight Loss

    Time frame: 12 Months

    Mean change in Absolute Weight Loss from baseline

Sponsors and collaborators

Lead sponsor

GI Windows, Inc.

Industry

Registry information

Official study title

Single Neodymium Magnet Anastomosis Procedure When Used to Create a Duodenal-Ileal Diversion for Subjects With Inadequate Weight Loss or Weight Regain Following Sleeve Gastrectomy

Acronym: SNAP-PS

Important dates

Study start
2021
Primary completion
2023
Study completion
2024
First posted
Sep 20, 2021
Registry last updated
Oct 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.